فرهاد زرگری , The Future of Pharma Marketing, Dramatic Changes, Burden of Chronic Disease, Policy-makers and Payers, Performance, Vision, Healthcare, Pharmerging,…

Osteoporos Int (2008) 19:399–428 DOI 10.1007/s00198-008-0560-z POSITION PAPER European guidance for the diagnosis and management of osteoporosis in postmenopausal women…

Denizar_Vianna_CLAPBio_meeting_Rio_Dec16th2011 [Modo de Compatibilidade] Universidade do Estado do Rio de Janeiro Policlínica Piquet Carneiro Instituto de Ensino e Pesquisa…

Roanoke College Economics Program Roanomics Volume 3, Issue 1 Summer and Fall 2012 From the Colonel’s Desk The economics program at Roanoke College has seen significant…

Κατανόηση της «Αξιολόγησης Ιατρικής Τεχνολογίας» (ΑΙΤ) Patients in Power 1o Πανελλήνιο Συνέδριο Ασθενών…

1. Disease  Management   September,  2013   2. The  Need  for  Disease  Management   •  There  are  myriad  trends  driving  demand  for  health  care,…

1. Health Economics- From Basics to Applied Part-I Nayyar Raza Kazmi 2.   3. Allocative efficiency Directing resources to their most productive use. Means assessing which…

1. Health Economics and Reimbursement Implications for Emerging Pharmaceutical/ Biotechnology Companies Quality Work • Valuable Strategies and Perspectives Results MaRS…

1. Entry into the Pharmaceutical and Medical Industry 2. Improving your chances of getting your first position within the pharmaceutical and medical industry The role of…